Administration of ADP355, but not scramble, decreased the serum ALT/ALP levels and the sensitivity of adipo(−/−) mice to TAA-induced liver fibrosis and necroinflammation (Fig. 5B–D). The gene discussed is GPT; the disease is Hepatic fibrosis.